Skip to main content
NCBI home page
Molecular Medicine logoLink to Molecular Medicine
. 1995 Nov;1(7):722–727.

Antigen-specific therapy for autoimmune disease: prospects for the prevention of insulin-dependent diabetes.

L C Harrison 1
PMCID: PMC2230010  PMID: 8612195

Full text

PDF
722

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkinson M. A., Maclaren N. K., Luchetta R. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes. 1990 Aug;39(8):933–937. doi: 10.2337/diab.39.8.933. [DOI] [PubMed] [Google Scholar]
  2. Bingley P. J., Bonifacio E., Gale E. A. Can we really predict IDDM? Diabetes. 1993 Feb;42(2):213–220. doi: 10.2337/diab.42.2.213. [DOI] [PubMed] [Google Scholar]
  3. Burstein H. J., Shea C. M., Abbas A. K. Aqueous antigens induce in vivo tolerance selectively in IL-2- and IFN-gamma-producing (Th1) cells. J Immunol. 1992 Jun 15;148(12):3687–3691. [PubMed] [Google Scholar]
  4. Critchfield J. M., Lenardo M. J. Antigen-induced programmed T cell death as a new approach to immune therapy. Clin Immunol Immunopathol. 1995 Apr;75(1):13–19. doi: 10.1006/clin.1995.1046. [DOI] [PubMed] [Google Scholar]
  5. De Aizpurua H. J., Wilson Y. M., Harrison L. C. Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes. Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9841–9845. doi: 10.1073/pnas.89.20.9841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Evavold B. D., Sloan-Lancaster J., Allen P. M. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol Today. 1993 Dec;14(12):602–609. doi: 10.1016/0167-5699(93)90200-5. [DOI] [PubMed] [Google Scholar]
  7. Gizurarson S., Bechgaard E. Intranasal administration of insulin to humans. Diabetes Res Clin Pract. 1991 May;12(2):71–84. doi: 10.1016/0168-8227(91)90083-p. [DOI] [PubMed] [Google Scholar]
  8. Gotfredsen C. F., Buschard K., Frandsen E. K. Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia. 1985 Dec;28(12):933–935. doi: 10.1007/BF00703140. [DOI] [PubMed] [Google Scholar]
  9. Harrison L. C., Chu S. X., DeAizpurua H. J., Graham M., Honeyman M. C., Colman P. G. Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes. J Clin Invest. 1992 Apr;89(4):1161–1165. doi: 10.1172/JCI115698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Harrison L. C. Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited. Immunol Today. 1992 Sep;13(9):348–352. doi: 10.1016/0167-5699(92)90170-C. [DOI] [PubMed] [Google Scholar]
  11. Honeyman M. C., Cram D. S., Harrison L. C. Glutamic acid decarboxylase 67-reactive T cells: a marker of insulin-dependent diabetes. J Exp Med. 1993 Feb 1;177(2):535–540. doi: 10.1084/jem.177.2.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Husby S., Mestecky J., Moldoveanu Z., Holland S., Elson C. O. Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J Immunol. 1994 May 1;152(9):4663–4670. [PubMed] [Google Scholar]
  13. Johnson J. G., Jenkins M. K. The role of anergy in peripheral T cell unresponsiveness. Life Sci. 1994;55(23):1767–1780. doi: 10.1016/0024-3205(94)90087-6. [DOI] [PubMed] [Google Scholar]
  14. Kaufman D. L., Clare-Salzler M., Tian J., Forsthuber T., Ting G. S., Robinson P., Atkinson M. A., Sercarz E. E., Tobin A. J., Lehmann P. V. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 1993 Nov 4;366(6450):69–72. doi: 10.1038/366069a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Keller R. J., Eisenbarth G. S., Jackson R. A. Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet. 1993 Apr 10;341(8850):927–928. doi: 10.1016/0140-6736(93)91215-8. [DOI] [PubMed] [Google Scholar]
  16. Kikutani H., Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol. 1992;51:285–322. doi: 10.1016/s0065-2776(08)60490-3. [DOI] [PubMed] [Google Scholar]
  17. Lombardi G., Sidhu S., Batchelor R., Lechler R. Anergic T cells as suppressor cells in vitro. Science. 1994 Jun 10;264(5165):1587–1589. doi: 10.1126/science.8202711. [DOI] [PubMed] [Google Scholar]
  18. Metzler B., Wraith D. C. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int Immunol. 1993 Sep;5(9):1159–1165. doi: 10.1093/intimm/5.9.1159. [DOI] [PubMed] [Google Scholar]
  19. Muir A., Peck A., Clare-Salzler M., Song Y. H., Cornelius J., Luchetta R., Krischer J., Maclaren N. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J Clin Invest. 1995 Feb;95(2):628–634. doi: 10.1172/JCI117707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Palmer J. P., Asplin C. M., Clemons P., Lyen K., Tatpati O., Raghu P. K., Paquette T. L. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science. 1983 Dec 23;222(4630):1337–1339. doi: 10.1126/science.6362005. [DOI] [PubMed] [Google Scholar]
  21. Petersen J. S., Karlsen A. E., Markholst H., Worsaae A., Dyrberg T., Michelsen B. Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice. Diabetes. 1994 Dec;43(12):1478–1484. doi: 10.2337/diab.43.12.1478. [DOI] [PubMed] [Google Scholar]
  22. Rudy G., Stone N., Harrison L. C., Colman P. G., McNair P., Brusic V., French M. B., Honeyman M. C., Tait B., Lew A. M. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol Med. 1995 Sep;1(6):625–633. [PMC free article] [PubMed] [Google Scholar]
  23. Tisch R., Yang X. D., Singer S. M., Liblau R. S., Fugger L., McDevitt H. O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 1993 Nov 4;366(6450):72–75. doi: 10.1038/366072a0. [DOI] [PubMed] [Google Scholar]
  24. Trentham D. E., Dynesius-Trentham R. A., Orav E. J., Combitchi D., Lorenzo C., Sewell K. L., Hafler D. A., Weiner H. L. Effects of oral administration of type II collagen on rheumatoid arthritis. Science. 1993 Sep 24;261(5129):1727–1730. doi: 10.1126/science.8378772. [DOI] [PubMed] [Google Scholar]
  25. Waldo F. B., van den Wall Bake A. W., Mestecky J., Husby S. Suppression of the immune response by nasal immunization. Clin Immunol Immunopathol. 1994 Jul;72(1):30–34. doi: 10.1006/clin.1994.1103. [DOI] [PubMed] [Google Scholar]
  26. Wegmann D. R., Gill R. G., Norbury-Glaser M., Schloot N., Daniel D. Analysis of the spontaneous T cell response to insulin in NOD mice. J Autoimmun. 1994 Dec;7(6):833–843. doi: 10.1006/jaut.1994.1066. [DOI] [PubMed] [Google Scholar]
  27. Weiner H. L., Friedman A., Miller A., Khoury S. J., al-Sabbagh A., Santos L., Sayegh M., Nussenblatt R. B., Trentham D. E., Hafler D. A. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol. 1994;12:809–837. doi: 10.1146/annurev.iy.12.040194.004113. [DOI] [PubMed] [Google Scholar]
  28. Weiner H. L., Mackin G. A., Matsui M., Orav E. J., Khoury S. J., Dawson D. M., Hafler D. A. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science. 1993 Feb 26;259(5099):1321–1324. doi: 10.1126/science.7680493. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ

RESOURCES